Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camille Roubille

Showing results (1-10 of 69) with videos related to

Pageof 7
Sort By:
Seminars in Arthritis and Rheumatism|November 16, 2013
Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature reviewCamille Roubille, Boulos Haraoui
Therapeutic Advances in Musculoskeletal Disease|August 2, 2013
Important issues at heart: cardiovascular risk management in rheumatoid arthritisCamille Roubille, Boulos Haraoui
The New England Journal of Medicine|October 15, 2025
Competency-Based Medical Education at the Front Lines of Patient CareKévin Yauy, Camille Roubille
The Journal of Rheumatology|June 3, 2019
Shifting from a Rheumatologic Point of View toward Patient-centered Care in Rheumatoid Arthritis with an Integrated Management of ComorbiditiesCamille Roubille, Pierre Fesler, Bernard Combe
International Journal of Cardiology|May 22, 2020
By half decrease of cardiovascular mortality in a Western country between 2000 and 2015: A contrasted picture advocating for a better management of comorbiditiesClaire Duflos, Camille Roubille, François Roubille
Journal of the American Heart Association|June 6, 2022
Idiopathic Recurrent Pericarditis: Not Really So Idiopathic?François Roubille, Clément Delmas, Camille Roubille
Autoimmunity Reviews|July 6, 2021
Arterial stiffness, the hidden face of cardiovascular risk in autoimmune and chronic inflammatory rheumatic diseasesMarie Berger, Pierre Fesler, Camille Roubille
Current Opinion in Lipidology|May 31, 2019
Is hypertriglyceridemia atherogenic?Fabien Huet, Camille Roubille, François Roubille
Expert Opinion on Pharmacotherapy|September 19, 2013
New and emerging treatments for osteoarthritis management: will the dream come true with personalized medicine?Camille Roubille, Jean-Pierre Pelletier, Johanne Martel-Pelletier
Rheumatology (Oxford, England)|December 1, 2021
Toward a holistic management of skin and joint disorders in PsA patientsAurélie Du-Thanh, Céline Girard, Jacques Morel, et al.
Pageof 7

Showing results (1-10 of 69) with videos related to

Sort By:
Pageof 7
Seminars in Arthritis and Rheumatism|November 16, 2013
Interstitial lung diseases induced or exacerbated by DMARDS and biologic agents in rheumatoid arthritis: a systematic literature reviewCamille Roubille, Boulos Haraoui
Therapeutic Advances in Musculoskeletal Disease|August 2, 2013
Important issues at heart: cardiovascular risk management in rheumatoid arthritisCamille Roubille, Boulos Haraoui
The New England Journal of Medicine|October 15, 2025
Competency-Based Medical Education at the Front Lines of Patient CareKévin Yauy, Camille Roubille
The Journal of Rheumatology|June 3, 2019
Shifting from a Rheumatologic Point of View toward Patient-centered Care in Rheumatoid Arthritis with an Integrated Management of ComorbiditiesCamille Roubille, Pierre Fesler, Bernard Combe
International Journal of Cardiology|May 22, 2020
By half decrease of cardiovascular mortality in a Western country between 2000 and 2015: A contrasted picture advocating for a better management of comorbiditiesClaire Duflos, Camille Roubille, François Roubille
Journal of the American Heart Association|June 6, 2022
Idiopathic Recurrent Pericarditis: Not Really So Idiopathic?François Roubille, Clément Delmas, Camille Roubille
Autoimmunity Reviews|July 6, 2021
Arterial stiffness, the hidden face of cardiovascular risk in autoimmune and chronic inflammatory rheumatic diseasesMarie Berger, Pierre Fesler, Camille Roubille
Current Opinion in Lipidology|May 31, 2019
Is hypertriglyceridemia atherogenic?Fabien Huet, Camille Roubille, François Roubille
Expert Opinion on Pharmacotherapy|September 19, 2013
New and emerging treatments for osteoarthritis management: will the dream come true with personalized medicine?Camille Roubille, Jean-Pierre Pelletier, Johanne Martel-Pelletier
Rheumatology (Oxford, England)|December 1, 2021
Toward a holistic management of skin and joint disorders in PsA patientsAurélie Du-Thanh, Céline Girard, Jacques Morel, et al.
Pageof 7